AI-powered pathology presents the NHS with a unique opportunity to enhance cancer detection. Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system.
CEO of Dxcover Limited, Mark Hegarty, offers an insight into their cutting-edge technology that can help save lives by detecting early signs of cancer.
Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
Dee Mathieson, Managing Director at Elekta Ltd, believes that NHS budgets need to directly address the cancer backlog - which remains the second largest cause of death, globally.
Małgorzata Anna Bogusz, Rapporteur of the EESC opinion SOC/677 – Europe’s beating cancer plan, argues here that the EU needs a new Marshall Plan for oncology.
A non-invasive test for the early detection of oesophageal cancer has been developed by a team of researchers at the Medical Research Council (MRC) Cancer Cell Unit and is now being rolled out across Scotland.
With the current focus on public health worldwide, Arthur Goudena, Marketing Manager of PHC Europe, explains how one of Europe’s leading biobanks plays a growing role in supporting medical research.
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
Jean-Pierre Leburton, and Olgica Milenkovic, Professors of Electrical and Computer Engineering at the University of Illinois at Urbana-Champaign, discuss how big data processing via bio-sensing, and blue energy production revolutionise solid-state nanopores.
European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.
